Glecaprevir/pibrentasvir
Drug timelines are a Plus or Pro feature.
12 regulatory and trial events tracked for Glecaprevir/pibrentasvir, covering 2019-03-04 to 2026-04-24. Get the full timeline:
Most recent: Clinical Trial Update: Study of the Pharmacokinetics and Safety of Glecaprevir/Pibrentasvir Initiated in Pregnancy in Women With Hepatitis C With and Without HIV [Phase 1, Phase 2]